1. Introduction {#sec1-ijerph-15-01715}
===============

Congenital anomalies (CAs) comprise a large, highly heterogeneous group of birth outcomes, usually classified according to the specific organ or system affected. CAs are an important cause of premature death, chronic illness and lifelong disability worldwide. According to the 2015 Global Burden of Disease study, CAs led to 8.5% (7.7--9.5%) of deaths under the age of 5 years \[[@B1-ijerph-15-01715]\]. Liu et al., using vital registration data, also concluded that CAs were the most important cause of death in countries with very low (\<10 per 1000 livebirths) and low (10--25 per 1000 livebirths) under-5 mortality rates \[[@B2-ijerph-15-01715]\]. It is also clear that CA-related mortality merits attention since, while nearly all leading causes of death registered some form of decrease from 2005 to 2015 \[[@B1-ijerph-15-01715]\], CAs, along with neonatal sepsis, were the exception without any significant change. Moreover, Oza et al. observed that the proportion of deaths from congenital disorders was relatively stable across the period (data for 2000--2013 in 194 countries), with the smallest relative decrease in risk being predicted for congenital disorders \[[@B3-ijerph-15-01715]\].

As one of the leading causes of infant mortality, monitoring CA-related deaths is a useful practice for epidemiological analysis of population trends, for surveillance, and for research geared to identifying possible risk factors and, by extension, establishing public health actions. Indeed, this is precisely one of the purposes of international initiatives focused on effective birth-defect surveillance, such as the European network of population-based registries for the epidemiologic monitoring of CAs (EUROCAT) or the International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR) \[[@B4-ijerph-15-01715],[@B5-ijerph-15-01715]\]. These are examples of successful collaborative networks of CA registries and programmes confronting varying degrees of coverage in associated countries \[[@B6-ijerph-15-01715]\].

Furthermore, most CAs are low-prevalence conditions and thus individually regarded as rare diseases (prevalence below 5 per 10,000 in the European Union). Indeed, rare CAs account for approximately 80% of subgroups used by EUROCAT for the monitoring of CAs \[[@B7-ijerph-15-01715]\]. Although epidemiological studies on rare diseases face different challenges, such as assembling large cohorts of affected individuals, there is continuous encouragement to analyse and enhance the available epidemiological information \[[@B8-ijerph-15-01715]\]. In this respect, official nationwide statistics provide uniform population-based data, which are useful as a complement to data from existing surveillance networks and disease-specific or patient registries. More specifically, mortality statistics cover 100% of the population and share some minimum criteria that facilitate temporal and spatial analysis. Accordingly, they furnish uniform, robust series for epidemiological study of low-prevalence diseases \[[@B9-ijerph-15-01715]\].

The use of Geographic Information Systems (GIS) and spatial analysis data has become commonplace in health research because of the potential for monitoring and tracking disease trends, cluster detection, and/or evaluating environmental hazards \[[@B10-ijerph-15-01715],[@B11-ijerph-15-01715]\]. Hence, an increasing number of studies have been combining GIS and epidemiological methods, as applied, for instance, to specific rare congenital diseases \[[@B12-ijerph-15-01715],[@B13-ijerph-15-01715]\] or to CAs as a whole \[[@B14-ijerph-15-01715],[@B15-ijerph-15-01715],[@B16-ijerph-15-01715]\]. Aside from studies published on the mortality of some CAs or small groups of CAs, however, to date there have been no specific temporal or spatial analyses that have focused on the rare CA group as such, and only some items of related useful information can be extracted from other analyses \[[@B17-ijerph-15-01715]\].

Accordingly, this study sought to analyse population-based mortality attributed to rare CAs, globally and by anatomic system according to the International Classification of Diseases, as well as for remarkable rare CAs, and assess the associated time trends and geographical differences in Spain. This information can be added to the studies on the occurrence of rare CAs, thus completing the background. It involved obtaining essential knowledge for better characterisation of nationwide distribution of this group of rare diseases, enhancing their visibility, and detecting local neighbourhood clusters which displayed a high risk of death from rare CAs. All this helps in establishing a baseline that can serve as reference for comparisons with future analyses (what can contribute to estimate the impact of possible modifying factors or measures influencing mortality attributed to rare CAs) or with comparable figures in other countries.

2. Materials and Methods {#sec2-ijerph-15-01715}
========================

Deaths due to CAs were sourced from annual mortality databases kept by the National Statistics Institute (NSI) of Spain, corresponding to population-based data for the period 1999--2013. Only ICD-10 (International Classification of Diseases, 10th Revision) codes deemed to be rare diseases by reason of their low prevalence were included for study purposes \[[@B18-ijerph-15-01715]\]. Therefore, we have considered as *rare CAs* those with a birth prevalence below 5 per 10,000. Causes of death due to rare CAs were grouped by ICD-10 category for the main types of CAs ([Table S1](#app1-ijerph-15-01715){ref-type="app"}), with a breakdown by date and place of death, sex, and date of birth. Annual populations categorised by sex and age at a municipal level were also obtained from the NSI, in order to calculate age-adjusted mortality rates for males, females and both sexes combined (expressed per 100,000 inhabitants). For the age-adjusted mortality rates, we used the Standard European Population as reference.

Time trends were assessed by joinpoint regression analysis, including two possible joinpoints across the 15 years of study. These regression models were calculated overall and by type of CA. The only exceptions were "*cleft lip and cleft palate*", "*CAs of eye, ear, face and neck*", and "*CAs of genital organs*", and this can be explained because although these three groups of rare CAs are included in the present study, their time trend analyses were not performed due to the extremely low number of deceases (6 in total) attributed to these CAs in the period 1999--2013.

Spatial analysis was performed for NSI population and mortality data, by municipality, sex and age group. Municipalities were aggregated into 326 districts, defined as divisions of Spanish territory pertaining to adjacent municipalities having similar geographical and historical features \[[@B19-ijerph-15-01715]\]. This spatial unit was chosen for the purposes of robustness and the stability of results based on a low number of deaths \[[@B20-ijerph-15-01715]\]. For the period 1999--2013, standardised mortality ratios (SMRs) were calculated by district, and subsequently smoothed in line with the conditional autoregressive model proposed by Besag et al. \[[@B21-ijerph-15-01715]\]. The Spanish mortality rate due to rare CAs across the whole period was taken as reference, so it corresponded to the SMR value of 1.00 (expected mortality). Smoothed SMRs make use of data from adjacent units, assuming a Poisson distribution and taking into account the spatial contiguity and heterogeneity of each unit. This enabled us to estimate the relative risk (RR) of death due to rare CAs by district and the associated posterior probability (PP). PP values show those districts with significantly higher (PP \> 0.80) or lower (PP \< 0.20) risk of death with respect to the expected for the country as reference. The geographical analysis was completed by cluster detection, with a radius of zero to 50 km being set around each of the main municipal population centres. The clusters are assessed as the circles with the maximum likelihood of containing more or fewer cases of rare-CA-related mortality than expected. Results were evaluated using the Monte Carlo simulation (999 iterations) with a 95% confidence interval (CI) \[[@B22-ijerph-15-01715]\]. All statistical analyses were performed using the Stata (StataCorp, College Station, TX, USA), Joinpoint (National Cancer Institute, Bethesda, MD, USA), R-INLA (Norwegian University of Science and Technology, Trondheim, Norway) and SaTScan (Martin Kulldorf, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA) computer software programmes, with ArcGIS software (Esri, Redlands, CA, USA) being used for cartographical representations.

Research Ethics
---------------

The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of the Instituto de Salud Carlos III (CEI 50/2013).

3. Results {#sec3-ijerph-15-01715}
==========

In Spain, there were 13,660 deaths (53.4% males, 46.6% females) due to rare CAs along the period 1999--2013. In terms of type of CA, the highest percentage (40.3%) of deaths corresponded to rare CAs of the circulatory system, followed by a 16.9% due to chromosomal abnormalities (not elsewhere classified), 14.5% due to other congenital malformations, and 9.2% due to rare CAs of the nervous system. In addition to the type of CA, [Table 1](#ijerph-15-01715-t001){ref-type="table"} shows the distribution of deaths according to EUROCAT subgroups of congenital anomalies, classified by anatomic system.

Distribution of deaths by age showed that 49.9% occurred in the first year of life, 6.3% occurred between the ages of 1 and 4 years, and the remaining 43.8% occurred later in life. The average age at death was 20.5 years (95% CI: 20.1--21.0), with this being higher among women (21.7 years; 95% CI: 21.0--22.4) than men (19.4 years; 95% CI: 18.9--20.1). From 1999 to 2013, the average age at death increased significantly, rising to nearly double the initial figure by the end of the period, i.e., from 16.6 years (95% CI: 15.1--18.1) in 1999 to 30.3 years (95% CI: 28.0--32.5) in 2013.

3.1. Time Trends {#sec3dot1-ijerph-15-01715}
----------------

Annual age-adjusted mortality rates displayed downward trends ([Figure 1](#ijerph-15-01715-f001){ref-type="fig"}), decreasing from 4.11 (95% CI: 3.86--4.38) per 100,000 inhabitants in 1999 to 1.77 (95% CI: 1.63--1.91) per 100,000 inhabitants in 2013 (annual percentage change, APC: −5.2%, *p* \< 0.001). This downward trend was reflected in both sexes, without any joinpoint, with a fall in male age-adjusted mortality rates from 4.39 (95% CI: 4.03--4.78) in 1999 to 1.79 (95% CI: 1.60--1.99) in 2013 (APC: −5.5%, *p* \< 0.001), and in female rates from 3.84 (95% CI: 3.50--4.22) in 1999 to 1.76 (95% CI: 1.57--1.97) in 2013 (APC: −4.8%, *p* \< 0.001).

[Table 2](#ijerph-15-01715-t002){ref-type="table"} includes the annual age-adjusted mortality rates (ARs) by sex and type of rare CA. Apart from the data for the CA grouped by body systems, it also includes defect specific results for all the defects for which at least 180 deaths (i.e., at least an average of 12 deaths per year) were observed in the study period. According to data shown by type of rare CA, the greatest fall corresponded to transposition of the great vessels, followed by hydrocephalus, hypoplastic left heart, and severe CHD as a group. Time trends were not significant for rare CAs of the digestive system, as well as neural tube defects, and chromosomal abnormalities (not elsewhere classified) and trisomy 18 in males, and rare CAs of the respiratory system and urinary system in women ([Table 2](#ijerph-15-01715-t002){ref-type="table"}).

3.2. Geographical Distribution {#sec3dot2-ijerph-15-01715}
------------------------------

[Table 3](#ijerph-15-01715-t003){ref-type="table"} shows the districts in which SMRs differed from the expected value for Spain along the 15 years studied (SMR = 1.00). As can be seen from the values registered for both sexes, lower-than-expected mortality was detected in 14 districts situated in the provinces of Alicante, Badajoz, Balearic Islands, Barcelona, Girona, Madrid, Pontevedra, Cantabria and Toledo. SMRs were higher than expected in 24 districts: of these, 20 (83.3%) corresponded to provinces lying in the south of Spain (Almería, Cádiz, Córdoba, Granada, Jaén, Málaga, Las Palmas, Tenerife, Seville, Ceuta and Murcia), two corresponded to provinces lying in the north (Asturias and León), and two corresponded to provinces lying in the west (Cáceres and Badajoz).

Detailed mapping made it easier to monitor spatial differences in risk of death due to rare CAs. [Figure 2](#ijerph-15-01715-f002){ref-type="fig"} depicts the geographical variability in smoothed SMRs, taking into account mortality registered in each district and its adjacent districts. According to the PP values associated with these smoothed SMRs, risk of death due to rare CAs was significantly higher than expected in districts situated in the south of Spain, with some exceptions ([Figure 3](#ijerph-15-01715-f003){ref-type="fig"}). This geographical pattern remained unchanged when males and females were analysed separately.

Lastly, the above mapping exercise was completed by identification of spatial clustering, with a higher-than-expected risk of mortality being detected in 6 clusters of municipalities situated in the south, and a lower risk being identified in the north (3 clusters), east (1 cluster) and centre (1 cluster) of the country. As before, the geographical distribution of clusters from both sexes combined, remained unchanged when males and females were analysed separately, and less significant groups were identified ([Figure 4](#ijerph-15-01715-f004){ref-type="fig"}).

4. Discussion {#sec4-ijerph-15-01715}
=============

Mortality is a major health-status indicator which is fairly well monitored for some common diseases \[[@B23-ijerph-15-01715]\]. Unfortunately, there is still a sizeable knowledge gap for large groups of rare diseases, and too many aspects relating to rare-disease mortality remain unknown. Rare CAs are not an exception, and not many studies have addressed the associated mortality. Such research is essential because, while mortality remains unknown, any interpretation of lifetime prevalence could well prove misleading. Failure to consider mortality data could lead to the conclusion that a disease was negligible if it caused death very early in life. This, in turn, could prevent the allocation of the precise health resources that could increase survival or survival under better conditions.

This population-based study on rare CAs shows the continuous downward trend in CA-related mortality and the geographical distribution of risk of death from these causes in Spain. In addition, it confirms that most deaths occur below 5 years of age, with the first year of life accounting for half of all CA-related deaths. Moreover, the average age at death caused by rare CAs corresponds to early adulthood (around 20 years old). Although such average age has significantly increased along the time (in accordance to the downward trend in CA-related mortality), it seems clear that greater efforts are needed to ascertain the exact determinants of such early death, in order to establish the most appropriate prevention measures. Nevertheless, this scenario is not stable. In a matter of just 15 years, the average age of CA-related death has doubled, which is a promising sign. This goes to show that, insofar as CAs are concerned, a change is taking place in the Spanish population. Moreover, given the degree of geographical heterogeneity that was detected, the determinants of CA-related mortality may not be uniformly distributed across the country, and special attention should therefore be paid to areas with the highest rates, and even to those with the lowest rates because, to some extent, such areas might serve as models. Comparison of these two types of areas might conceivably yield some clues for prevention.

One of our study's most relevant findings is the above mentioned observed fall in age-adjusted mortality rates from 1999 to 2013 across all the different subgroups of rare CAs (with the exception of those of the digestive system, for which no statistically significant decrease was found). This decrease (for which we ruled out methodological issues as a cause) is in line with the increase in the average age at death attributed to rare CAs, since both are interrelated. Both findings could also be due to a number of other reasons. The treatment and care of patients with CAs---even prenatally---likely had an influence on the mortality figures, though lack of data means that this cannot be quantified. Similarly, advances in prenatal diagnosis make for better preparedness and the referral of the deliveries of severely affected pregnancies to tertiary hospitals, where more adequate care can be provided at birth and during the neonatal period. It has been shown, for instance, that prenatal diagnosis of congenital heart defects allows for early preemptive stabilisation, and is associated with improved early clinical status \[[@B24-ijerph-15-01715]\]. Improved prenatal diagnosis also must have an impact, in the sense that better detection of CAs in the foetus increases the likelihood of interruption of affected pregnancies. This means that a higher number of elective terminations of pregnancy due to foetal anomalies (ETOPFA) will reduce the number of affected newborn infants, and this may in turn affect the mortality figures. In fact, infant CA mortality in a given country is higher when prevalence of ETOPFA is lower, and it thus follows that increases over time in the ETOPFA rate would tend to lower the infant mortality rate \[[@B25-ijerph-15-01715]\]. Furthermore, the severity of the defects has to be considered, in that the most severely affected cases (those with a higher risk of postnatal death) will more probably be detected prenatally, with a considerable number of subsequent ETOPFA, thereby also influencing mortality figures by reducing them.

It should be said that, based on EUROCAT data, the prevalence of some CAs, particularly severe congenital heart defects, was reported to have increased in Europe, from 2004 to 2012 \[[@B25-ijerph-15-01715]\]. While these data also included ETOPFA, the number or proportion of ETOPFA among the cases was not specified. Hence, the increase *per se* could not be taken to mean that the number of newborn infants with these types of defects also increased. The authors speculated that this might reflect increases in maternal obesity and diabetes, both of which are well-known risk factors for CAs. For the purposes of our study, if the number of ETOPFA was high, this could in fact have reduced the postnatal mortality figure. This is a good example of the complexity of the situation and its interpretation.

It is noteworthy that 56.1% of deaths attributed to rare CAs occur before the age of 5 years, and even more striking that 49.9% occur in the first year of life. This is an important item of information because it narrows down the age at which the risk of death is highest, and consequently the age at which follow-up should somehow be different, so as to ensure that the determinants of early death are properly approached. Furthermore, it provides some evidence of the need for strategic allocation of resources specifically required for that segment of the population. This facilitates analysis and identification of the hospital(s) and local or district services that should be reinforced, through strengthening the workforce and/or providing adequate materials and infrastructure. Another strategy for reducing CA-related mortality could lie in designating some national reference hospitals, services and units specialised in the care of specific diseases (here in Spain the equivalent designation is known as Reference Centres, Services, and Units of the National Health System; *Centros, Servicios y Unidades de Referencia*, CSUR). There are data in the literature showing, for instance, that the lower number of patients attended at heart surgery centres is associated with higher neonatal mortality among cases with transposition of the great arteries \[[@B26-ijerph-15-01715]\].

In terms of geographical distribution, risk of death was observed to be consistently higher in the south of Spain, and specifically in certain districts. While this type of epidemiological finding can sometimes generate concern among the population \[[@B11-ijerph-15-01715]\], it should preferably be seen as indicating where in-depth research would be needed into the causes of that distribution of mortality. Further analyses, beyond the scope of this study, could reveal some possible ways of minimising the risk.

Our findings could prove useful as a base for comparison with other countries, or as a reference in time to assess possible changes and the impact of different measures in the future. In contrast to other approaches that use multisource data-integration for rare-CA prevalence estimates \[[@B7-ijerph-15-01715]\], we propose that the results of this nationwide registry-based study on mortality be used as a potential contributor for the monitoring of rare CAs. This could be a simple, effective, complementary way of improving epidemiological surveillance in countries addressing current difficulties in pooling cases from different registries (i.e., individual linkage between CAs and rare--disease registries) although of course, mortality statistics should not be considered an optimal source of data for case identification. It could also benefit those programmes that form part of the EUROCAT network but have incomplete geographical coverage of their country, such as the population-based CA registries in Spain \[[@B4-ijerph-15-01715]\].

Regarding the clinical impact of CAs, it is evident the influence of the important cost associated with birth defects \[[@B27-ijerph-15-01715]\], as well as the increase in disability adjusted life years (DALYs) rates and years lived with disability (YLDs) for CAs \[[@B1-ijerph-15-01715],[@B28-ijerph-15-01715]\]. In addition, terminations of pregnancy for CAs were almost three times more frequent than the combination of infant deaths and stillbirths with CA, which clearly must affect the global burden of disease \[[@B17-ijerph-15-01715]\], and this should be taken into account when interpreting any figure.

This retrospective descriptive study has several limitations, such as the inability to link exposure to outcome in individuals, and to control for confounding factors. Therefore, it cannot be used to determine an association between a risk factor and disease. Consequently, additional research in this sense is needed for rare CAs.

Although the use of underlying cause of death underestimates case identification when compared to multiple-cause analysis, it is nonetheless an effective approach to mortality directly attributable to rare CAs. Some authors have estimated that mortality due to congenital anomalies for the under-5 age group is likely to be a fourfold underestimate \[[@B29-ijerph-15-01715]\]. If this were also applied to Spain, it would mean that the situation could be rather striking, something that yet again would make it advisable to focus attention on this younger stratum of the population. On the other hand, differences in diagnostic quality or coding practices over time or among regions might bias our results, even though the death registry officially follows a standardised, uniform methodology.

The use of ICD for rare diseases research is challenging and in fact the lack of appropriate coding makes difficult, and sometimes impossible, the study of a particular CA without a specific ICD code \[[@B8-ijerph-15-01715]\]. In this paper, the analysis of rare CAs (globally and by system) provides a general view of this public health problem, even though some misclassification issues cannot completely be ruled out.

Considering quality issues of deaths certificates, the differences and incompatibilities between original underlying cause of death and final main condition were assessed previously \[[@B30-ijerph-15-01715]\]. In that study, Johansson and Westerling reported the lowest percentage of differences for CAs, in comparison to other ICD chapters, which is reassuring.

Despite these limitations mortality statistics provide broad temporal and geographical coverage and continue to be a very useful tool for studying the epidemiology of low--prevalence diseases \[[@B9-ijerph-15-01715],[@B20-ijerph-15-01715]\], either for epidemiological research as well as for health monitoring \[[@B30-ijerph-15-01715]\]. In addition, mortality databases enhance the ability to collect cases diagnosed after the early neonatal period (lifetime detection), thereby becoming a complementary data source for rare-CA studies.

5. Conclusions {#sec5-ijerph-15-01715}
==============

In conclusion, this is the first nationwide population-based study to focus on mortality due to rare CAs. Our results contribute to the monitoring of rare CAs along 15 years in Spain, by providing evidence of the continuous decline in mortality rates and illustrate some geographical differences in the risk of death. These findings are not only useful for assessing the burden of low-prevalence CAs in Spain, but also serve as evidence which might be taken into account by health authorities, in order to identify possible risk factors, adopt appropriate preventive measures, implement and evaluate health policies and healthcare plans ensuring equality and equity, with the ultimate purpose of achieving better health for all.

The authors would like to thank the members and staff of the Spanish Rare Diseases Registries Research Network (Spain RDR) for their invaluable expertise in matters pertaining to the ICD and identification of rare diseases.

The following are available online at <http://www.mdpi.com/1660-4601/15/8/1715/s1>, Table S1: ICD--10 codes corresponding to rare congenital anomalies (low--prevalence congenital anomalies).
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###### 

Number of deaths registered in Spain (1999--2013) by underlying cause of death, this being a rare CA. The following list of rare congenital anomalies is based on EUROCAT subgroups of congenital anomalies \[[@B4-ijerph-15-01715]\]. Only those EUROCAT defects considered as rare diseases with corresponding ICD-10 codes are displayed.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Rare CAs as Cause of Death                                                                                                                     Number of Deaths              
  ---------------------------------------------------------------- ----------------------------------------------------------------------------- ------------------ ---------- ----------
  **Rare CAs of the Nervous System**                                                                                                                                           

  **Nervous system**                                               **Q00, Q01, Q02, Q03, Q04, Q05, Q06, Q07**                                    **1251**           **645**    **606**

  Neural Tube Defects                                              Q00, Q01, Q05                                                                 272                140        132

  Anencephalus and similar                                         Q00                                                                           97                 49         48

  Encephalocele                                                    Q01                                                                           15                 10         5

  Myelomeningocele/Spina Bifida                                    Q05                                                                           160                81         79

  Hydrocephalus                                                    Q03                                                                           199                119        80

  Severe microcephaly                                              Q02                                                                           54                 24         30

  Arhinencephaly/holoprosencephaly                                 Q04.1, Q04.2                                                                  59                 24         35

  **Rare CAs of the Eye, Ear, Face and Neck**                                                                                                                                  

  **Eye**                                                          **Q10--Q15**                                                                  **1**              **0**      **1**

  Anophthalmos/microphthalmos                                      Q11.0, Q11.1, Q11.2                                                           1                  0          1

  Anophthalmos                                                     Q11.0, Q11.1                                                                  0                  0          0

  Congenital cataract                                              Q12.0                                                                         0                  0          0

  Congenital glaucoma                                              Q15.0                                                                         0                  0          0

  **Ear, face and neck**                                           **Q16, Q17, Q18**                                                             **0**              **0**      **0**

  Anotia                                                           Q16.0                                                                         0                  0          0

  **Rare CAs of the Circulatory System**                                                                                                                                       

  **Congenital Heart Defects (CHD)**                               **Q20--Q26**                                                                  **4927**           **2780**   **2147**

  Severe CHD                                                       Q20.0, Q20.1, Q20.3, Q20.4, Q21.2, Q21.3,\                                    1475               841        634
                                                                   Q22.0, Q22.4, Q22.5, Q22.6, Q23.0, Q23.2, Q23.3, Q23.4, Q25.1, Q25.2, Q26.2                                 

  Common arterial truncus                                          Q20.0                                                                         44                 20         24

  Double outlet right ventricle                                    Q20.1                                                                         19                 12         7

  Transposition of great vessels                                   Q20.3                                                                         235                151        84

  Single ventricle                                                 Q20.4                                                                         75                 40         35

  AVSD                                                             Q21.2                                                                         126                52         74

  Tetralogy of Fallot                                              Q21.3                                                                         360                210        150

  Triscuspid atresia and stenosis                                  Q22.4                                                                         34                 15         19

  Ebstein's anomaly                                                Q22.5                                                                         75                 32         43

  Pulmonary valve stenosis                                         Q22.1                                                                         6                  4          2

  Pulmonary valve atresia                                          Q22.0                                                                         5                  2          3

  Aortic valve atresia/stenosis                                    Q23.0                                                                         57                 37         20

  Mitral valve anomalies                                           Q23.2, Q23.3                                                                  27                 15         12

  Hypoplastic left heart                                           Q23.4                                                                         256                155        101

  Hypoplastic right heart                                          Q22.6                                                                         5                  3          2

  Coarctation of aorta                                             Q25.1                                                                         150                93         57

  Total anomalous pulmonary venous return                          Q26.2                                                                         7                  4          3

  PDA as only CHD in term infants (GA + 37 weeks)                  Q25.0                                                                         290                155        135

  **Rare CAs of the Respiratory System**                                                                                                                                       

  **Respiratory**                                                  **Q30.0, Q32--Q34**                                                           **347**            **203**    **144**

  Choanal atresia                                                  Q30.0                                                                         8                  5          3

  **Cleft lip and Cleft Palate**                                                                                                                                               

  **Oro-facial clefts**                                            **Q35--Q37**                                                                  **4**              **1**      **3**

  Cleft lip with or without cleft\                                 Q36, Q37                                                                      0                  0          0
  palate                                                                                                                                                                       

  Cleft palate                                                     Q35                                                                           4                  1          3

  **Rare CAs of the Digestive System**                                                                                                                                         

  **Digestive system**                                             **Q38--Q45**                                                                  **1092**           **593**    **499**

  Oesophageal atresia with or without tracheaoesophageal fistula   Q39.0--Q39.1                                                                  107                55         52

  Duodenal atresia or stenosis                                     Q41.0                                                                         11                 7          4

  Atresia or stenosis of other parts of small intestine            Q41.1--Q41.8                                                                  17                 9          8

  Ano-rectal atresia and stenosis                                  Q42.0--Q42.3                                                                  6                  4          2

  Hirschsprung's disease                                           Q43.1                                                                         47                 27         20

  Atresia of bile ducts                                            Q44.2                                                                         55                 30         25

  Annular pancreas                                                 Q45.1                                                                         0                  0          0

  **Rare CAs of the Urinary System**                                                                                                                                           

  **Urinary**                                                      **Q60--Q64, Q79.4**                                                           **756**            **393**    **363**

  Bilateral renal agenesis including Potter syndrome               Q60.1, Q60.6                                                                  84                 53         31

  Renal dysplasia                                                  Q61.4                                                                         28                 20         8

  Bladder exstrophy and/or epispadia                               Q64.0, Q64.1                                                                  2                  2          0

  Posterior urethral valve and/or prune belly                      Q64.2, Q64.3, Q79.4                                                           7                  6          1

  **Rare CAs of Genital Organs**                                                                                                                                               

  **Genital**                                                      **Q50--Q52, Q54--Q56**                                                        **1**              **1**      **0**

  Hypospadias                                                      Q54                                                                           1                  1          0

  Indeterminate sex                                                Q56                                                                           0                  0          0

  **Rare CAs of the Musculoskeletal System**                                                                                                                                   

  Craniosynostosis                                                 Q75.0                                                                         6                  3          3

  Diaphragmatic hernia                                             Q79.0                                                                         339                191        148

  **Limb**                                                         **Q65--Q74**                                                                  **56**             **24**     **32**

  Limb reduction defects                                           Q71--Q73                                                                      0                  0          0

  Polydactyly                                                      Q69                                                                           0                  0          0

  Syndactyly                                                       Q70                                                                           0                  0          0

  **Abdominal wall defects**                                       **Q79.2, Q79.3, Q79.5**                                                       **66**             **42**     **24**

  Gastroschisis                                                    Q79.3                                                                         44                 30         14

  Omphalocele                                                      Q79.2                                                                         22                 12         10

  **Other Rare Congenital Malformations**                                                                                                                                      

  **Other anomalies/syndromes**                                                                                                                                                

  Congenital skin disorders                                        Q80--Q82                                                                      93                 62         31

  Fetal alcohol syndrome                                           Q86.0                                                                         2                  2          0

  Situs inversus                                                   Q89.3                                                                         31                 16         15

  Conjoined twins                                                  Q89.4                                                                         11                 2          9

  **Rare Chromosomal Abnormalities, not elsewhere classified**                                                                                                                 

  **Chromosomal**                                                  **Q90--Q92, Q93, Q96--Q99**                                                   **2312**           **1068**   **1244**

  Patau syndrome/trisomy 13                                        Q91.4--Q91.7                                                                  143                62         81

  Edwards syndrome / trisomy 18                                    Q91.0--Q91.3                                                                  288                81         207

  Turner syndrome                                                  Q96                                                                           23                 1          22

  Klinefelter syndrome                                             Q98.0--Q98.4                                                                  3                  3          0
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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###### 

Annual age-adjusted mortality rates (ARs) and 95% confidence intervals (CIs), by sex and type of rare congenital anomaly. Time trends results are shown as annual percentage change (APC) and *p*-value.

  ---------------- -------------------------------------------- -------------------------------------------------------------- ----------------------- ----------------------- ----------------------- ----------------------- ------------- ------------------- ------------- ------------------- ------------- -------------------
  **Year**         **Rare CAs of the Nervous System**           **Neural Tube Defects**                                                                                                                                                                                                                          
  **Both Sexes**   **Men**                                      **Women**                                                      **Both Sexes**          **Men**                 **Women**                                                                                                                         
  ***n***          **AR (CI)**                                  ***n***                                                        **AR (CI)**             ***n***                 **AR (CI)**             ***n***                 **AR (CI)**   ***n***             **AR (CI)**   ***n***             **AR (CI)**   
  1999             93                                           0.37 (0.29--0.45)                                              47                      0.35 (0.25--0.47)       46                      0.39 (0.28--0.53)       23            0.10 (0.06--0.15)   11            0.08 (0.04--0.15)   12            0.12 (0.06--0.20)
  2000             95                                           0.36 (0.29--0.45)                                              51                      0.37 (0.27--0.50)       44                      0.35 (0.25--0.48)       25            0.10 (0.06--0.15)   12            0.09 (0.05--0.16)   13            0.10 (0.05--0.18)
  2001             87                                           0.34 (0.27--0.43)                                              54                      0.42 (0.32--0.56)       33                      0.26 (0.17--0.37)       24            0.09 (0.06--0.14)   15            0.11 (0.06--0.19)   9             0.07 (0.03--0.14)
  2002             79                                           0.29 (0.23--0.37)                                              34                      0.25 (0.17--0.35)       45                      0.35 (0.25--0.47)       15            0.07 (0.04--0.11)   9             0.08 (0.04--0.15)   6             0.06 (0.02--0.12)
  2003             93                                           0.34 (0.27--0.42)                                              47                      0.34 (0.25--0.46)       46                      0.34 (0.25--0.46)       20            0.07 (0.04--0.11)   14            0.10 (0.05--0.17)   6             0.05 (0.02--0.10)
  2004             95                                           0.31 (0.32--0.39)                                              56                      0.38 (0.28--0.50)       39                      0.26 (0.18--0.36)       18            0.06 (0.03--0.10)   9             0.05 (0.02--0.11)   9             0.06 (0.03--0.13)
  2005             82                                           0.26 (0.21--0.33)                                              45                      0.29 (0.21--0.40)       37                      0.24 (0.16--0.33)       16            0.05 (0.03--0.09)   10            0.07 (0.03--0.13)   6             0.03 (0.01--0.08)
  2006             80                                           0.25 (0.21--0.33)                                              46                      0.28 (0.20--0.37)       34                      0.23 (0.16--0.32)       21            0.06 (0.04--0.10)   12            0.06 (0.03--0.12)   9             0.06 (0.03--0.11)
  2007             80                                           0.25 (0.20--0.31)                                              41                      0.25 (0.18--0.34)       39                      0.25 (0.18--0.35)       16            0.05 (0.03--0.08)   6             0.04 (0.01--0.09)   10            0.06 (0.03--0.11)
  2008             73                                           0.22 (0.18--0.28)                                              35                      0.21 (0.14--0.29)       38                      0.25 (0.17--0.34)       16            0.05 (0.03--0.08)   11            0.07 (0.03--0.12)   5             0.03 (0.01--0.08)
  2009             74                                           0.21 (0.17--0.27)                                              33                      0.19 (0.13--0.26)       41                      0.24 (0.17--0.34)       20            0.06 (0.03--0.09)   8             0.05 (0.02--0.10)   12            0.07 (0.03--0.12)
  2010             93                                           0.26 (0.21--0.32)                                              42                      0.24 (0.17--0.32)       51                      0.28 (0.21--0.38)       12            0.03 (0.01--0.05)   4             0.02 (0.01--0.06)   8             0.04 (0.01--0.08)
  2011             82                                           0.22 (0.17--0.27)                                              44                      0.23 (0.16--0.31)       38                      0.20 (0.14--0.29)       18            0.04 (0.02--0.07)   6             0.03 (0.01--0.06)   12            0.06 (0.03--0.10)
  2012             77                                           0.21 (0.16--0.26)                                              37                      0.21 (0.14--0.29)       40                      0.20 (0.14--0.28)       14            0.03 (0.02--0.05)   6             0.03 (0.01--0.06)   8             0.04 (0.01--0.08)
  2013             68                                           0.20 (0.15--0.25)                                              33                      0.18 (0.12--0.26)       35                      0.22 (0.15--0.31)       14            0.04 (0.02--0.06)   7             0.04 (0.01--0.08)   7             0.04 (0.01--0.08)
  APC              −4.49 (*p* \< 0.001)                         −5.19 (*p* \< 0.001)                                           −3.87 (*p* \< 0.001)    −6.60 (*p* \< 0.001)    −2.40 (*p* = 0.30)      −8.24 (*p* \< 0.001)                                                                                      
  **Year**         **Hydrocephalus**                            **Rare CAs of the Circulatory System**                                                                                                                                                                                                           
  **Both Sexes**   **Men**                                      **Women**                                                      **Both Sexes**          **Men**                 **Women**                                                                                                                         
  ***n***          **AR (CI)**                                  ***n***                                                        **AR (CI)**             ***n***                 **AR (CI)**             ***n***                 **AR (CI)**   ***n***             **AR (CI)**   ***n***             **AR (CI)**   
  1999             20                                           0.08 (0.05--0.13)                                              14                      0.11 (0.06--0.19)       6                       0.05 (0.02--0.11)       486           1.90 (1.73--2.09)   274           2.11 (1.86--2.38)   212           1.69 (1.46--1.95)
  2000             22                                           0.09 (0.05--0.14)                                              13                      0.10 (0.05--0.18)       9                       0.07 (0.03--0.14)       480           1.85 (1.68--2.03)   268           2.06 (1.82--2.34)   212           1.63 (1.40--1.88)
  2001             12                                           0.05 (0.02--0.08)                                              6                       0.04 (0.02--0.10)       6                       0.05 (0.02--0.11)       387           1.51 (1.36--1.67)   224           1.69 (1.46--1.93)   163           1.33 (1.12--1.56)
  2002             22                                           0.08 (0.05--0.12)                                              10                      0.07 (0.03--0.13)       12                      0.09 (0.05--0.17)       421           1.60 (1.44--1.76)   241           1.79 (1.57--2.04)   180           1.39 (1.19--1.62)
  2003             15                                           0.05 (0.03--0.09)                                              7                       0.05 (0.02--0.10)       8                       0.06 (0.02--0.12)       391           1.38 (1.24--1.53)   211           1.48 (1.28--1.70)   180           1.28 (1.09--1.49)
  2004             16                                           0.05 (0.03--0.09)                                              12                      0.08 (0.04--0.14)       4                       0.03 (0.01--0.07)       404           1.39 (1.25--1.53)   254           1.71 (1.50--1.94)   150           1.05 (0.88--1.24)
  2005             12                                           0.04 (0.02--0.07)                                              10                      0.06 (0.03--0.11)       2                       0.02 (0.00--0.06)       341           1.16 (1.03--1.29)   205           1.37 (1.19--1.58)   136           0.93 (0.78--1.11)
  2006             9                                            0.03 (0.01--0.06)                                              7                       0.05 (0.02--0.10)       2                       0.01 (0.00--0.05)       380           1.21 (1.09--1.34)   220           1.38 (1.20--1.58)   160           1.04 (0.88--1.22)
  2007             11                                           0.03 (0.02--0.06)                                              7                       0.04 (0.02--0.09)       4                       0.03 (0.01--0.08)       318           0.99 (0.88--1.11)   170           1.09 (0.93--1.26)   140           0.9 (0.75--1.07)
  2008             14                                           0.04 (0.02--0.07)                                              7                       0.04 (0.01--0.08)       7                       0.05 (0.02--0.10)       350           1.05 (0.94--1.17)   190           1.14 (0.98--1.32)   160           0.95 (0.81--1.12)
  2009             9                                            0.02 (0.01--0.05)                                              4                       0.02 (0.01--0.06)       5                       0.03 (0.01--0.07)       341           0.97 (0.86--1.08)   190           1.06 (0.91--1.23)   151           0.87 (0.73--1.02)
  2010             13                                           0.04 (0.02--0.06)                                              8                       0.05 (0.02--0.09)       5                       0.02 (0.01--0.06)       349           0.97 (0.87--1.08)   190           1.06 (0.91--1.23)   159           0.88 (0.74--1.03)
  2011             10                                           0.03 (0.01--0.05)                                              9                       0.04 (0.02--0.09)       1                       0.01 (0.00--0.04)       321           0.9 (0.80--1.01)    184           1.01 (0.87--1.17)   137           0.8 (0.66--0.95)
  2012             6                                            0.02 (0.01--0.03)                                              1                       0.01 (0.00--0.03)       5                       0.02 (0.01--0.06)       295           0.81 (0.71--0.91)   153           0.84 (0.71--0.99)   142           0.77 (0.64--0.92)
  2013             8                                            0.02 (0.01--0.05)                                              4                       0.02 (0.01--0.06)       4                       0.02 (0.01--0.06)       246           0.67 (0.59--0.77)   134           0.71 (0.59--0.85)   112           0.64 (0.52--0.78)
  APC              −9.65 (*p* \< 0.001)                         −9.11 (*p* \< 0.001)                                           −9.08 (*p* \< 0.001)    −6.44 (*p* \< 0.001)    −6.70 (*p* \< 0.001)    −6.08 (*p* \< 0.001)                                                                                      
  **Year**         **Severe CHD**                               **Transposition of Great Vessels**                                                                                                                                                                                                               
  **Both Sexes**   **Men**                                      **Women**                                                      **Both Sexes**          **Men**                 **Women**                                                                                                                         
  ***n***          **AR (CI)**                                  ***n***                                                        **AR (CI)**             ***n***                 **AR (CI)**             ***n***                 **AR (CI)**   ***n***             **AR (CI)**   ***n***             **AR (CI)**   
  1999             145                                          0.59 (0.50--0.70)                                              89                      0.72 (0.57--0.89)       56                      0.47 (0.35--0.62)       28            0.12 (0.08--0.18)   18            0.16 (0.09--0.25)   10            0.09 (0.04--0.16)
  2000             148                                          0.59 (0.49--0.69)                                              75                      0.59 (0.46--0.74)       73                      0.58 (0.45--0.74)       30            0.13 (0.08--0.18)   18            0.15 (0.09--0.24)   12            0.10 (0.05--0.18)
  2001             100                                          0.39 (0.32--0.48)                                              56                      0.42 (0.31--0.55)       44                      0.36 (0.26--0.49)       15            0.06 (0.03--0.10)   9             0.07 (0.03--0.14)   6             0.05 (0.02--0.11)
  2002             119                                          0.46 (0.38--0.56)                                              66                      0.49 (0.38--0.63)       53                      0.43 (0.32--0.57)       22            0.09 (0.06--0.14)   15            0.11 (0.06--0.19)   7             0.06 (0.03--0.13)
  2003             102                                          0.38 (0.31--0.47)                                              52                      0.39 (0.29--0.51)       50                      0.38 (0.28--0.50)       13            0.05 (0.03--0.09)   7             0.06 (0.02--0.12)   6             0.05 (0.02--0.11)
  2004             117                                          0.40 (0.33--0.49)                                              79                      0.53 (0.42--0.67)       38                      0.27 (0.19--0.37)       22            0.08 (0.05--0.12)   13            0.09 (0.05--0.16)   9             0.07 (0.03--0.13)
  2005             101                                          0.33 (0.27--0.41)                                              58                      0.37 (0.28--0.49)       43                      0.29 (0.21--0.39)       17            0.06 (0.03--0.09)   13            0.08 (0.04--0.15)   4             0.03 (0.01--0.07)
  2006             109                                          0.35 (0.29--0.43)                                              60                      0.38 (0.29--0.49)       49                      0.33 (0.24--0.44)       15            0.05 (0.03--0.08)   9             0.06 (0.02--0.11)   6             0.04 (0.01--0.09)
  2007             101                                          0.31 (0.25--0.38)                                              63                      0.39 (0.29--0.50)       38                      0.23 (0.16--0.32)       12            0.04 (0.02--0.07)   9             0.06 (0.03--0.11)   3             0.02 (0.00--0.06)
  2008             83                                           0.26 (0.20--0.32)                                              48                      0.29 (0.21--0.38)       35                      0.22 (0.15--0.31)       14            0.05 (0.02--0.08)   7             0.05 (0.02--0.09)   7             0.05 (0.02--0.10)
  2009             80                                           0.23 (0.18--0.29)                                              51                      0.29 (0.21--0.38)       29                      0.17 (0.11--0.25)       12            0.04 (0.02--0.07)   9             0.06 (0.03--0.11)   3             0.02 (0.00--0.06)
  2010             71                                           0.19 (0.15--0.25)                                              38                      0.21 (0.14--0.28)       33                      0.18 (0.13--0.26)       9             0.03 (0.01--0.05)   6             0.03 (0.01--0.07)   3             0.02 (0.00--0.06)
  2011             65                                           0.18 (0.14--0.23)                                              35                      0.19 (0.13--0.26)       30                      0.17 (0.12--0.25)       11            0.03 (0.01--0.05)   9             0.05 (0.02--0.09)   2             0.01 (0.00--0.04)
  2012             68                                           0.19 (0.14--0.24)                                              36                      0.20 (0.14--0.27)       32                      0.18 (0.12--0.25)       9             0.03 (0.01--0.05)   6             0.03 (0.01--0.08)   3             0.02 (0.00--0.05)
  2013             66                                           0.18 (0.14--0.24)                                              35                      0.19 (0.13--0.26)       31                      0.18 (0.12--0.26)       6             0.02 (0.01--0.04)   3             0.02 (0.00--0.05)   3             0.02 (0.00--0.05)
  APC              −8.55 (*p* \< 0.001)                         −8.59 (*p* \< 0.001)                                           −8.53 (*p* \< 0.001)    −11.80 (*p* \< 0.001)   −11.03 (*p* \< 0.001)   −12.43 (*p* \< 0.001)                                                                                     
  **Year**         **Hypoplastic Left Heart**                   **Rare CAs of the Respiratory System**                                                                                                                                                                                                           
  **Both Sexes**   **Men**                                      **Women**                                                      **Both Sexes**          **Men**                 **Women**                                                                                                                         
  ***n***          **AR (CI)**                                  ***n***                                                        **AR (CI)**             ***n***                 **AR (CI)**             ***n***                 **AR (CI)**   ***n***             **AR (CI)**   ***n***             **AR (CI)**   
  1999             23                                           0.11 (0.07--0.16)                                              13                      0.12 (0.06--0.21)       10                      0.10 (0.05--0.18)       25            0.11 (0.07--0.17)   11            0.10 (0.05--0.18)   14            0.13 (0.07--0.21)
  2000             19                                           0.09 (0.05--0.14)                                              9                       0.08 (0.04--0.16)       10                      0.10 (0.05--0.18)       23            0.10 (0.06--0.15)   14            0.12 (0.07--0.21)   9             0.07 (0.03--0.14)
  2001             22                                           0.10 (0.06--0.15)                                              11                      0.10 (0.05--0.18)       11                      0.11 (0.05--0.19)       24            0.11 (0.07--0.16)   16            0.14 (0.08--0.22)   8             0.08 (0.03--0.15)
  2002             25                                           0.11 (0.07--0.16)                                              14                      0.12 (0.07--0.20)       11                      0.10 (0.05--0.18)       22            0.09 (0.05--0.14)   14            0.11 (0.06--0.19)   8             0.07 (0.03--0.14)
  2003             21                                           0.09 (0.05--0.14)                                              13                      0.11 (0.06--0.18)       8                       0.07 (0.03--0.14)       35            0.14 (0.10--0.19)   24            0.18 (0.12--0.28)   11            0.09 (0.04--0.16)
  2004             21                                           0.08 (0.05--0.13)                                              15                      0.12 (0.07--0.19)       6                       0.05 (0.02--0.11)       31            0.12 (0.08--0.17)   17            0.12 (0.07--0.20)   14            0.12 (0.06--0.19)
  2005             17                                           0.06 (0.04--0.10)                                              9                       0.07 (0.03--0.13)       8                       0.06 (0.03--0.12)       25            0.09 (0.06--0.14)   15            0.11 (0.06--0.18)   10            0.08 (0.04--0.14)
  2006             21                                           0.08 (0.05--0.12)                                              15                      0.10 (0.06--0.17)       6                       0.05 (0.02--0.10)       20            0.07 (0.04--0.11)   12            0.08 (0.04--0.14)   8             0.06 (0.02--0.11)
  2007             17                                           0.06 (0.04--0.10)                                              13                      0.09 (0.05--0.15)       4                       0.03 (0.01--0.08)       28            0.10 (0.06--0.14)   17            0.11 (0.06--0.18)   11            0.08 (0.04--0.15)
  2008             16                                           0.05 (0.03--0.09)                                              11                      0.07 (0.04--0.13)       5                       0.04 (0.01--0.08)       20            0.06 (0.04--0.10)   10            0.07 (0.03--0.12)   10            0.06 (0.03--0.11)
  2009             11                                           0.04 (0.02--0.06)                                              7                       0.04 (0.02--0.09)       4                       0.03 (0.01--0.07)       22            0.06 (0.04--0.10)   14            0.08 (0.04--0.14)   8             0.04 (0.02--0.09)
  2010             12                                           0.04 (0.02--0.07)                                              8                       0.05 (0.02--0.10)       4                       0.03 (0.01--0.07)       22            0.07 (0.04--0.10)   15            0.09 (0.05--0.14)   7             0.04 (0.02--0.09)
  2011             12                                           0.04 (0.02--0.07)                                              6                       0.04 (0.01--0.08)       6                       0.04 (0.01--0.09)       32            0.10 (0.07--0.14)   16            0.10 (0.05--0.16)   16            0.1 (0.06--0.17)
  2012             10                                           0.03 (0.02--0.06)                                              4                       0.02 (0.01--0.06)       6                       0.04 (0.01--0.09)       23            0.07 (0.05--0.11)   14            0.08 (0.05--0.14)   9             0.06 (0.03--0.11)
  2013             9                                            0.03 (0.01--0.06)                                              7                       0.04 (0.02--0.09)       2                       0.01 (0.00--0.05)       16            0.05 (0.03--0.08)   9             0.06 (0.03--0.11)   7             0.05 (0.02--0.09)
  APC              −9.00 (*p* \< 0.001)                         −7.47 (*p* \< 0.001)                                           −10.53 (*p* \< 0.001)   −4.07 (*p* \< 0.001)    −4.46 (*p* \< 0.001)    −3.72 (*p* = 0.87)                                                                                        
  **Year**         **Rare CAs of the Digestive System**         **Rare CAs of the Urinary System**                                                                                                                                                                                                               
  **Both Sexes**   **Men**                                      **Women**                                                      **Both Sexes**          **Men**                 **Women**                                                                                                                         
  ***n***          **AR (CI)**                                  ***n***                                                        **AR (CI)**             ***n***                 **AR (CI)**             ***n***                 **AR (CI)**   ***n***             **AR (CI)**   ***n***             **AR (CI)**   
  1999             42                                           0.15 (0.10--0.21)                                              28                      0.2 (0.13--0.29)        14                      0.11 (0.06--0.19)       60            0.16 (0.12--0.22)   39            0.24 (0.16--0.34)   21            0.10 (0.05--0.17)
  2000             37                                           0.14 (0.09--0.19)                                              21                      0.15 (0.09--0.24)       16                      0.12 (0.07--0.21)       70            0.17 (0.13--0.22)   37            0.20 (0.13--0.29)   33            0.14 (0.09--0.21)
  2001             37                                           0.12 (0.08--0.17)                                              22                      0.16 (0.10--0.25)       15                      0.08 (0.04--0.15)       52            0.13 (0.09--0.18)   24            0.14 (0.09--0.22)   28            0.11 (0.07--0.18)
  2002             42                                           0.15 (0.11--0.21)                                              18                      0.15 (0.09--0.23)       24                      0.15 (0.09--0.24)       50            0.12 (0.09--0.17)   27            0.16 (0.10--0.24)   23            0.09 (0.05--0.15)
  2003             48                                           0.16 (0.11--0.21)                                              34                      0.22 (0.15--0.31)       14                      0.1 (0.05--0.18)        46            0.11 (0.08--0.16)   27            0.15 (0.10--0.23)   19            0.07 (0.04--0.13)
  2004             56                                           0.18 (0.13--0.23)                                              29                      0.17 (0.11--0.26)       27                      0.18 (0.12--0.27)       35            0.08 (0.05--0.11)   19            0.09 (0.05--0.15)   16            0.07 (0.03--0.12)
  2005             64                                           0.19 (0.15--0.25)                                              32                      0.19 (0.13--0.28)       32                      0.19 (0.13--0.28)       49            0.11 (0.08--0.15)   23            0.11 (0.07--0.17)   26            0.11 (0.07--0.17)
  2006             39                                           0.13 (0.09--0.18)                                              17                      0.12 (0.07--0.19)       22                      0.14 (0.08--0.22)       51            0.12 (0.08--0.16)   32            0.17 (0.11--0.24)   19            0.07 (0.04--0.13)
  2007             61                                           0.16 (0.12--0.21)                                              35                      0.19 (0.13--0.27)       26                      0.13 (0.08--0.20)       39            0.09 (0.06--0.13)   22            0.12 (0.07--0.18)   17            0.06 (0.03--0.11)
  2008             58                                           0.15 (0.11--0.20)                                              33                      0.17 (0.11--0.24)       25                      0.13 (0.08--0.20)       44            0.11 (0.08--0.15)   16            0.08 (0.05--0.14)   28            0.13 (0.08--0.20)
  2009             46                                           0.12 (0.09--0.16)                                              19                      0.11 (0.06--0.17)       27                      0.13 (0.08--0.20)       39            0.07 (0.05--0.10)   16            0.06 (0.03--0.11)   23            0.08 (0.05--0.13)
  2010             53                                           0.13 (0.10--0.18)                                              24                      0.12 (0.07--0.18)       29                      0.15 (0.10--0.23)       61            0.13 (0.09--0.17)   31            0.15 (0.10--0.22)   30            0.10 (0.06--0.16)
  2011             68                                           0.15 (0.12--0.20)                                              36                      0.18 (0.12--0.25)       32                      0.12 (0.08--0.19)       44            0.08 (0.06--0.12)   22            0.09 (0.05--0.14)   22            0.08 (0.04--0.13)
  2012             56                                           0.12 (0.09--0.16)                                              29                      0.13 (0.08--0.19)       27                      0.12 (0.07--0.18)       50            0.07 (0.05--0.10)   25            0.09 (0.05--0.14)   25            0.06 (0.04--0.10)
  2013             46                                           0.09 (0.06--0.13)                                              25                      0.1 (0.06--0.15)        21                      0.09 (0.05--0.15)       63            0.11 (0.08--0.14)   31            0.13 (0.08--0.19)   32            0.09 (0.05--0.14)
  APC              −1.49 (*p* = 0.20)                           −2.61 (*p* = 0.10)                                             −0.16 (*p* = 0.90)      −3.96 (*p* \< 0.001)    −5.10 (*p* \< 0.001)    −2.08 (*p* = 0.20)                                                                                        
  **Year**         **Rare CAs of the Musculoskeletal System**   **Diaphragmatic Hernia**                                                                                                                                                                                                                         
  **Both Sexes**   **Men**                                      **Women**                                                      **Both Sexes**          **Men**                 **Women**                                                                                                                         
  ***n***          **AR (CI)**                                  ***n***                                                        **AR (CI)**             ***n***                 **AR (CI)**             ***n***                 **AR (CI)**   ***n***             **AR (CI)**   ***n***             **AR (CI)**   
  1999             61                                           0.26 (0.20--0.34)                                              34                      0.29 (0.20--0.41)       27                      0.23 (0.15--0.34)       32            0.15 (0.10--0.21)   19            0.18 (0.11--0.27)   13            0.13 (0.07--0.22)
  2000             59                                           0.25 (0.19--0.32)                                              27                      0.23 (0.15--0.34)       32                      0.26 (0.18--0.38)       26            0.12 (0.08--0.18)   16            0.15 (0.08--0.24)   10            0.10 (0.05--0.18)
  2001             49                                           0.21 (0.15--0.28)                                              31                      0.26 (0.17--0.37)       18                      0.15 (0.09--0.25)       29            0.13 (0.09--0.19)   19            0.17 (0.10--0.27)   10            0.10 (0.05--0.18)
  2002             51                                           0.21 (0.15--0.27)                                              25                      0.20 (0.13--0.30)       26                      0.21 (0.14--0.32)       22            0.10 (0.06--0.15)   14            0.12 (0.07--0.20)   8             0.07 (0.03--0.14)
  2003             67                                           0.23 (0.18--0.30)                                              35                      0.24 (0.17--0.34)       32                      0.22 (0.15--0.32)       30            0.13 (0.09--0.18)   17            0.14 (0.08--0.22)   13            0.11 (0.06--0.19)
  2004             40                                           0.13 (0.09--0.19)                                              22                      0.16 (0.10--0.25)       18                      0.11 (0.06--0.18)       13            0.05 (0.03--0.09)   9             0.07 (0.03--0.13)   4             0.03 (0.01--0.09)
  2005             46                                           0.15 (0.11--0.21)                                              19                      0.12 (0.07--0.19)       27                      0.19 (0.12--0.28)       23            0.09 (0.05--0.13)   12            0.08 (0.04--0.15)   11            0.09 (0.04--0.16)
  2006             50                                           0.17 (0.12--0.22)                                              35                      0.23 (0.16--0.33)       15                      0.10 (0.06--0.17)       25            0.09 (0.06--0.14)   17            0.12 (0.07--0.19)   8             0.06 (0.03--0.12)
  2007             43                                           0.14 (0.10--0.19)                                              25                      0.16 (0.10--0.24)       18                      0.12 (0.07--0.20)       18            0.06 (0.04--0.10)   9             0.06 (0.03--0.12)   9             0.07 (0.03--0.13)
  2008             56                                           0.18 (0.13--0.23)                                              28                      0.17 (0.11--0.25)       28                      0.18 (0.12--0.27)       25            0.09 (0.06--0.13)   11            0.07 (0.04--0.13)   14            0.10 (0.05--0.17)
  2009             40                                           0.12 (0.08--0.16)                                              21                      0.12 (0.07--0.19)       19                      0.11 (0.06--0.17)       16            0.05 (0.03--0.08)   8             0.05 (0.02--0.10)   8             0.05 (0.02--0.10)
  2010             47                                           0.14 (0.10--0.18)                                              28                      0.17 (0.11--0.24)       19                      0.10 (0.06--0.17)       26            0.08 (0.06--0.12)   17            0.11 (0.06--0.17)   9             0.06 (0.03--0.11)
  2011             62                                           0.18 (0.14--0.23)                                              28                      0.16 (0.11--0.23)       34                      0.20 (0.14--0.28)       25            0.08 (0.05--0.12)   12            0.07 (0.04--0.13)   13            0.09 (0.05--0.15)
  2012             28                                           0.08 (0.06--0.12)                                              10                      0.06 (0.03--0.11)       18                      0.11 (0.06--0.18)       11            0.04 (0.02--0.06)   3             0.02 (0.00--0.05)   8             0.05 (0.02--0.11)
  2013             29                                           0.08 (0.06--0.12)                                              11                      0.07 (0.03--0.12)       18                      0.10 (0.06--0.17)       18            0.06 (0.04--0.09)   8             0.05 (0.02--0.10)   10            0.07 (0.03--0.13)
  APC              −5.75 (*p* \< 0.001)                         −6.48 (*p* \< 0.001)                                           −4.76 (*p* \< 0.001)    −6.45 (*p* \< 0.001)    −8.09 (*p* \< 0.001)    −3.85 (*p* \< 0.001)                                                                                      
  **Year**         **Other Rare Congenital Malformations**      **Rare Chromosomal Abnormalities, Not Elsewhere Classified**                                                                                                                                                                                     
  **Both Sexes**   **Men**                                      **Women**                                                      **Both Sexes**          **Men**                 **Women**                                                                                                                         
  ***n***          **AR (CI)**                                  ***n***                                                        **AR (CI)**             ***n***                 **AR (CI)**             ***n***                 **AR (CI)**   ***n***             **AR (CI)**   ***n***             **AR (CI)**   
  1999             158                                          0.63 (0.53--0.74)                                              87                      0.68 (0.54--0.85)       71                      0.58 (0.45--0.74)       157           0.55 (0.46--0.55)   64            0.55 (0.46--0.65)   93            0.67 (0.53--0.83)
  2000             168                                          0.64 (0.55--0.75)                                              87                      0.67 (0.53--0.83)       81                      0.62 (0.48--0.78)       119           0.42 (0.35--0.51)   55            0.42 (0.35--0.51)   64            0.47 (0.36--0.61)
  2001             154                                          0.61 (0.51--0.71)                                              89                      0.68 (0.54--0.85)       65                      0.53 (0.40--0.68)       116           0.38 (0.31--0.46)   47            0.38 (0.31--0.46)   69            0.47 (0.36--0.61)
  2002             158                                          0.57 (0.48--0.68)                                              84                      0.62 (0.49--0.78)       74                      0.52 (0.40--0.66)       123           0.4 (0.33--0.49)    51            0.4 (0.33--0.49)    72            0.48 (0.37--0.62)
  2003             136                                          0.47 (0.39--0.56)                                              84                      0.57 (0.45--0.71)       52                      0.36 (0.26--0.48)       163           0.51 (0.43--0.60)   63            0.51 (0.43--0.60)   100           0.67 (0.54--0.82)
  2004             123                                          0.41 (0.34--0.50)                                              67                      0.44 (0.34--0.57)       56                      0.38 (0.28--0.50)       171           0.5 (0.43--0.59)    80            0.5 (0.43--0.59)    91            0.55 (0.44--0.68)
  2005             143                                          0.44 (0.37--0.53)                                              77                      0.46 (0.36--0.58)       66                      0.43 (0.33--0.55)       176           0.5 (0.43--0.59)    78            0.5 (0.43--0.59)    98            0.57 (0.54--0.70)
  2006             130                                          0.42 (0.34--0.50)                                              73                      0.46 (0.36--0.58)       57                      0.37 (0.28--0.49)       148           0.39 (0.33--0.46)   68            0.39 (0.33--0.46)   80            0.45 (0.35--0.56)
  2007             122                                          0.36 (0.30--0.43)                                              70                      0.41 (0.32--0.53)       52                      0.3 (0.22--0.40)        161           0.41 (0.35--0.48)   85            0.41 (0.35--0.48)   76            0.41 (0.32--0.52)
  2008             136                                          0.38 (0.32--0.46)                                              70                      0.39 (0.31--0.50)       66                      0.37 (0.28--0.48)       146           0.36 (0.30--0.43)   69            0.33 (0.26--0.42)   77            0.39 (0.31--0.50)
  2009             126                                          0.35 (0.29--0.42)                                              65                      0.34 (0.26--0.44)       61                      0.35 (0.27--0.46)       175           0.42 (0.36--0.50)   93            0.44 (0.36--0.55)   82            0.41 (0.32--0.51)
  2010             121                                          0.31 (0.26--0.38)                                              70                      0.35 (0.27--0.45)       51                      0.28 (0.21--0.37)       172           0.42 (0.36--0.49)   79            0.37 (0.29--0.47)   93            0.46 (0.37--0.57)
  2011             117                                          0.32 (0.26--0.38)                                              59                      0.32 (0.24--0.41)       58                      0.32 (0.24--0.42)       164           0.39 (0.34--0.46)   78            0.36 (0.29--0.46)   86            0.43 (0.34--0.54)
  2012             99                                           0.25 (0.21--0.31)                                              51                      0.26 (0.19--0.35)       48                      0.25 (0.18--0.34)       159           0.38 (0.32--0.44)   77            0.36 (0.28--0.45)   82            0.4 (0.32--0.51)
  2013             87                                           0.23 (0.18--0.29)                                              42                      0.22 (0.16--0.30)       45                      0.24 (0.18--0.29)       163           0.37 (0.31--0.43)   81            0.36 (0.28--0.45)   82            0.38 (0.30--0.47)
  APC              −6.66 (*p* \< 0.001)                         −7.19 (*p* \< 0.001)                                           −6.00 (*p* \< 0.001)    −1.77 (*p* \< 0.001)    −0.16 (*p* = 0.90)      −3.05 (*p* \< 0.001)                                                                                      
  **Year**         **Edwards Syndrome/Trisomy 18**                                                                                                                                                                                                                                                               
  **Both Sexes**   **Men**                                      **Women**                                                                                                                                                                                                                                        
  ***n***          **AR (CI)**                                  ***n***                                                        **AR (CI)**             ***n***                 **AR (CI)**                                                                                                                       
  1999             26                                           0.12 (0.08--0.18)                                              4                       0.04 (0.01--0.09)       22                      0.21 (0.13--0.32)                                                                                         
  2000             20                                           0.09 (0.06--0.14)                                              7                       0.06 (0.03--0.13)       13                      0.12 (0.07--0.21)                                                                                         
  2001             21                                           0.10 (0.06--0.15)                                              4                       0.04 (0.01--0.09)       17                      0.16 (0.09--0.26)                                                                                         
  2002             14                                           0.06 (0.03--0.10)                                              5                       0.04 (0.01--0.10)       9                       0.08 (0.04--0.15)                                                                                         
  2003             26                                           0.11 (0.07--0.16)                                              3                       0.02 (0.01--0.07)       23                      0.20 (0.13--0.30)                                                                                         
  2004             24                                           0.10 (0.06--0.14)                                              7                       0.05 (0.02--0.11)       17                      0.14 (0.08--0.23)                                                                                         
  2005             26                                           0.10 (0.06--0.15)                                              9                       0.07 (0.03--0.13)       17                      0.13 (0.08--0.21)                                                                                         
  2006             17                                           0.06 (0.04--0.10)                                              3                       0.02 (0.00--0.06)       14                      0.11 (0.06--0.18)                                                                                         
  2007             19                                           0.07 (0.04--0.10)                                              4                       0.03 (0.01--0.07)       15                      0.11 (0.06--0.18)                                                                                         
  2008             21                                           0.07 (0.04--0.11)                                              9                       0.06 (0.03--0.11)       12                      0.08 (0.04--0.15)                                                                                         
  2009             17                                           0.05 (0.03--0.09)                                              6                       0.04 (0.01--0.08)       11                      0.07 (0.04--0.13)                                                                                         
  2010             17                                           0.05 (0.03--0.09)                                              3                       0.02 (0.00--0.06)       14                      0.09 (0.05--0.16)                                                                                         
  2011             20                                           0.06 (0.04--0.10)                                              8                       0.05 (0.02--0.10)       12                      0.08 (0.04--0.14)                                                                                         
  2012             9                                            0.03 (0.01--0.06)                                              4                       0.03 (0.01--0.06)       5                       0.03 (0.01--0.08)                                                                                         
  2013             11                                           0.04 (0.02--0.06)                                              5                       0.03 (0.01--0.07)       6                       0.04 (0.01--0.09)                                                                                         
  APC              −6.60 (*p* \< 0.001)                         −2.44 (*p* = 0.30)                                             −8.24 (*p* \< 0.001)                                                                                                                                                              
  ---------------- -------------------------------------------- -------------------------------------------------------------- ----------------------- ----------------------- ----------------------- ----------------------- ------------- ------------------- ------------- ------------------- ------------- -------------------
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###### 

Standardised mortality ratio 1999--2013 (95% CI) for rare congenital anomalies, by sex. Only districts with statistically significant values are shown.

  Standardised Mortality Ratio for Rare Congenital Anomalies, 1999--2013 (95% CI)                                                                
  --------------------------------------------------------------------------------- ------------ ------- ------------------- ------------------- -------------------
  Marquesado                                                                        Alicante     E       0.69 (0.48--0.97)   --                  --
  Central                                                                           Alicante     E       0.76 (0.64--0.90)   0.78 (0.62--0.98)   0.74 (0.57--0.94)
  Meridional                                                                        Alicante     E       0.84 (0.71--0.98)   0.80 (0.63--0.99)   --
  Badajoz                                                                           Badajoz      W       0.68 (0.47--0.94)   0.58 (0.33--0.95)   --
  Ibiza                                                                             Baleares     E \*    --                  --                  0.42 (0.17--0.86)
  Mallorca                                                                          Baleares     E \*    0.71 (0.61--0.83)   0.66 (0.53--0.82)   0.77 (0.62--0.95)
  Osona                                                                             Barcelona    NE      --                  0.57 (0.32--0.94)   --
  Penedès                                                                           Barcelona    NE      0.76 (0.58--0.98)   --                  0.62 (0.39--0.94)
  Vallès Oriental                                                                   Barcelona    NE      0.76 (0.61--0.94)   --                  0.69 (0.48--0.95)
  Vallès Occidental                                                                 Barcelona    NE      0.71 (0.62--0.82)   0.68 (0.56--0.83)   0.75 (0.61--0.92)
  Litoral del Norte                                                                 Castellón    E       --                  0.42 (0.13--0.97)   --
  Cerdanya                                                                          Girona       NE      0.00 (0.00--0.87)   --                  --
  La Selva                                                                          Girona       NE      0.63 (0.43--0.90)   0.58 (0.32--0.96)   --
  Bajo Cinca                                                                        Huesca       N       --                  0.00 (0.00--0.96)   --
  Costa                                                                             Lugo         NW      --                  --                  0.22 (0.02--0.79)
  Sur Occidental                                                                    Madrid       C       0.61 (0.52--0.72)   0.62 (0.49--0.77)   0.61 (0.47--0.78)
  Litoral                                                                           Pontevedra   NW      0.76 (0.65--0.89)   0.76 (0.60--0.94)   0.78 (0.61--0.97)
  Costera                                                                           Cantabria    N       0.62 (0.50--0.76)   0.61 (0.45--0.81)   0.63 (0.46--0.85)
  Sagra--Toledo                                                                     Toledo       C       0.71 (0.53--0.92)   0.60 (0.39--0.88)   --
  Riberas del Júcar                                                                 Valencia     E       --                  --                  0.67 (0.44--0.99)
  **Significantly Higher than the Expected for the Country as Reference**                                                                        
  Campo de Níjar y Bajo Andarax                                                     Almería      SE      1.25 (1.02--1.52)   --                  1.40 (1.04--1.83)
  Ávila                                                                             Avila        C       --                  1.85 (1.05--3.00)   --
  Don Benito                                                                        Badajoz      W       1.43 (1.02--1.94)   --                  --
  Osona                                                                             Barcelona    NE      --                  --                  1.48 (1.02--2.07)
  Arlanzón                                                                          Burgos       N       --                  1.40 (1.01--1.88)   --
  Caceres                                                                           Caceres      W       1.42 (1.02--1.86)   1.82 (1.28--2.52)   1.44 (1.14--1.80)
  Campiña de Cádiz                                                                  Cadiz        SW      1.20 (1.01--1.42)   --                  --
  Los Pedroches                                                                     Cordoba      S       1.47 (1.01--2.07)   --                  --
  Campiña Baja                                                                      Cordoba      S       1.29 (1.11--1.50)   --                  1.35 (1.07--1.67)
  Las Colonias                                                                      Cordoba      S       1.95 (1.05--3.00)   2.13 (1.02--3.92)   --
  Campiña Alta                                                                      Cordoba      S       1.33 (1.04--1.67)   --                  1.73 (1.26--2.31)
  Serranía Baja                                                                     Cuenca       C       --                  3.63 (1.17--8.47)   --
  La Vega                                                                           Granada      S       1.32 (1.15--1.51)   1.29 (1.06--1.56)   1.36 (1.11--1.65)
  Guadix                                                                            Granada      S       1.77 (1.11--2.67)   --                  --
  Montefrío                                                                         Granada      S       --                  --                  3.56 (1.77--6.36)
  Sierra                                                                            Huelva       SW      --                  --                  2.16 (1.08--3.87)
  La Loma                                                                           Jaén         S       1.44 (1.03--1.96)   --                  1.85 (1.19--2.16)
  Campiña del Sur                                                                   Jaén         S       1.66 (1.36--2.02)   1.88 (1.44--2.42)   1.41 (1.00--1.92)
  Mágina                                                                            Jaén         S       --                  --                  2.21 (1.06--4.06)
  Montaña de Riaño                                                                  León         N       2.37 (1.08--4.49)   --                  --
  Guadalhorce                                                                       Malaga       S       1.31 (1.19--1.43)   1.34 (1.18--1.52)   1.27 (1.11--1.45)
  Vélez--Málaga                                                                     Malaga       S       1.40 (1.10--1.75)   1.51 (1.10--2.02)   --
  Río Segura                                                                        Murcia       SE      1.22 (1.07--1.37)   1.31 (1.11--1.53)   --
  Suroeste y Valle del Guadalentín                                                  Murcia       SE      1.31 (1.05--1.60)   1.41 (1.06--1.84)   --
  Campo de Cartagena                                                                Murcia       SE      1.59 (1.36--1.84)   1.68 (1.37--2.04)   1.48 (1.16--1.85)
  Grado                                                                             Asturias     N       --                  --                  2.33 (1.16--4.17)
  Oviedo                                                                            Asturias     N       1.40 (1.17--1.66)   1.55 (1.22--1.94)   --
  Gran Canaria                                                                      Las Palmas   SW \*   1.34 (1.20--1.49)   1.33 (1.14--1.54)   1.36 (1.15--1.59)
  Sur de Tenerife                                                                   Tenerife     SW \*   1.30 (1.11--1.51)   1.32 (1.06--1.62)   1.28 (1.01--1.60)
  Sierra Norte                                                                      Seville      SW      1.77 (1.22--2.49)   2.40 (1.54--3.57)   --
  La Vega                                                                           Seville      SW      1.27 (1.15--1.39)   1.29 (1.14--1.47)   1.24 (1.07--1.42)
  Ceuta                                                                             Ceuta        S       1.61 (1.18--2.14)   1.97 (1.34--2.80)   --

\* Island territories (Canary Islands and Balearic Islands). C = Centre; E = east; N = north; NE = north-east; NW = north-west; S = south; SE = south-east; SW = south-west; W = west; Dashes (--) represent not significant standardised mortality ratio for that category.
